Chinese Journal of Tissue Engineering Research ›› 2019, Vol. 23 ›› Issue (30): 4804-4810.doi: 10.3969/j.issn.2095-4344.1419

Previous Articles     Next Articles

Comparative analysis of hydroxyapatite, β-tricalcium phosphate, and carbonated hydroxyapatite alginate dental pulp replacement materials

Cheng Yang1, Liu Min1, Zhu Zhongyan2, Gao Shasha3
  

  1. 1Stomatological Hospital Affiliated to Southwest Medical University, Luzhou 646000, Sichuan Province, China; 2Stomatological Department, Zigong First People's Hospital, Zigong 643000, Sichuan Province, China; 3Deyang Stomatological Hospital, Deyang 618000, Sichuan Province, China
  • Received:2019-05-12 Online:2019-10-28 Published:2019-10-28
  • Contact: Liu Min, Chief physician, Stomatological Hospital Affiliated to Southwest Medical University, Luzhou 646000, Sichuan Province, China
  • About author:Cheng Yang, Master candidate, Attending physician, Stomatological Hospital Affiliated to Southwest Medical University, Luzhou 646000, Sichuan Province, China
  • Supported by:

    Sichuan Provincial Department of Science and Technology-Luzhou Bureau of Science and Technology-Luzhou Medical College Joint Project, No. LY-51 (to LM)

Abstract:

BACKGROUND: There are many kinds of dental pulp replacement materials, which can be divided into natural biological materials, artificial synthetic materials, and composite materials. Various types of materials can also be synthesized by chemical and biological methods, all of which have their own advantages and disadvantages.
OBJECTIVE: To compare cytotoxicity and biological compatibility of three kinds of alveolar bone repair materials including hydroxyapatite/β-tricalcium phosphate, carbonated hydroxyapatite alginate, and pure hydroxyapatite.
METHODS: Mouse pre-osteoblasts and human osteoblasts were cultured together with the leaching liquor of three biomaterials respectively. Cell mitochondrial activity was detected by XTT assay (cells cultured separately were used as the control group), and cytotoxicity was detected by crystal violet assay (cells cultured in DMSO were used as the control group).Twenty Wistar rats purchased from Beijing Vital River Laboratory Animal Technology Co., Ltd were used to prepare the alveolar bone defect model of the right maxillary central incisor. Then the alveolar bone defect models were randomly divided into four groups. In the control group, no material was implanted into the bone defect region. In the other three groups, hydroxyapatite/β-tricalcium phosphate, carbonated hydroxyapatite alginate, and pure hydroxyapatite were implanted into the bone defect region. At 7, 21 and 42 days after implantation, serum concentrations of receptor activator for nuclear factor-κB ligand and osteoprotegerin were measured. This study was approved by Animal Ethics Committee, Southwest Medical University, China (approval No. IACUC20170315-07).
RESULTS AND CONCLUSION: There was no significant difference in the mitochondrial activity of the mouse preosteoblasts and human osteoblasts between three material groups and the control group (P > 0.05). The mitochondrial activity of mouse preosteoblasts and human osteoblasts was higher in the hydroxyapatite/β-tricalcium phosphate and carbonated hydroxyapatite alginate groups than in the pure hydroxyapatite group (P < 0.05). The cytotoxicity of the mouse pre-osteoblasts and human osteoblasts in the three material groups was lower than that in the control group (P < 0.05). Among three material groups, the leaching liquor of carbonated hydroxyapatite alginate had the lowest toxicity to the two kinds of cells. Serum concentration of receptor activator for nuclear factor-κB ligand at 7 days after implantation of carbonated hydroxyapatite alginate was significantly lower than that at 21 days after biomaterial implantation, and serum concentration of osteoprotegerin at 42 days after biomaterial implantation was significantly higher than that at 7 and 21 days (P < 0.001). These results suggest that carbonated hydroxyapatite alginate exhibits better biocompatibility than hydroxyapatite/β-tricalcium phosphate and pure hydroxyapatite.

Key words: hydroxyapatite, β-tricalcium phosphate, carbonated hydroxyapatite alginate, tissue engineering, Jaw defects, bone regeneration, biological scaffold material, biocompatibility

CLC Number: